A surprising cohort study published in JAMA Network Open indicates that breast cancer survivors have a reduced risk of developing Alzheimer’s dementia compared to those without cancer history. Adjusted for age and comorbidities, the findings challenge prior beliefs about cognitive decline following cancer treatments and suggest potential neuroprotective effects of some oncological therapies, prompting new avenues for understanding the interaction between cancer biology and neurodegeneration.